{
    "Trade/Device Name(s)": [
        "ARCHITECT iGentamicin",
        "ARCHITECT iGentamicin Calibrators (A-F)"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K102699",
    "Predicate Device Reference 510(k) Number(s)": [
        "K935376"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCD",
        "DLJ"
    ],
    "Summary Letter Date": "April 1, 2011",
    "Summary Letter Received Date": "February 17, 2011",
    "Submission Date": "February 16, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.3450",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Gentamicin Test System",
        "Calibrators, Drug Specific"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Gentamicin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT iGentamicin chemiluminescent immunoassay and calibrators for quantitative determination of gentamicin in serum or plasma",
    "Indications for Use Summary": "For quantitative determination of gentamicin in human serum or plasma to aid in diagnosis and treatment of gentamicin overdose and for therapy monitoring; calibrators used to calibrate the system for this purpose",
    "fda_folder": "Toxicology"
}